Immunoscore in the WHO Classification of Digestive System Tumours
March 04, 2020 12:30 ET
|
HalioDx
Immunoscore® in the WHO Classification of Digestive System Tumours Immune response is now part of the Essential and Desirable Diagnostic Criteria for Colorectal Cancers in the 5th edition of the...
Immunoscore to support Immuno-oncology and microbiome research within the ONCOBIOME consortium
September 30, 2019 08:00 ET
|
HalioDx
Immunoscore® to support Immuno-oncology and microbiome research within the ONCOBIOME consortium A 15M€ European granted consortium led by Laurence Zitvogel from Gustave Roussy in Villejuif.HalioDx...
HalioDx lève 18,5 millions d'euros dans un tour de Série B
January 17, 2018 01:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Communiqué de presse 17...
HalioDx closed a Series B round of €18.5 million (US$22.3 million)
January 17, 2018 01:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release ...
HalioDx receives CLIA Compliance for Immunoscore® Colon
June 21, 2017 11:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
HalioDx receives CLIA Compliance for...
HalioDx : Immunosign® gene signature assesses LTX-315 ability to turn 'cold' tumors 'hot' at ASCO 2017
June 05, 2017 09:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunosign® gene signature assesses...
HalioDx : HalioDx highlights use of Immunosign® to define CAR T-cell therapy signature in tumor at ASCO 2017
June 05, 2017 09:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
HalioDx highlights use of Immunosign® to...
HalioDx : Immunoscore Colon prognostic performance confirmed in data presented by Mayo Clinic at ASCO 2017
June 03, 2017 09:00 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunoscore® Colon prognostic performance...
HalioDx : Immunoscore®, Immunosign® and Halioseek(TM) at ASCO 2017
May 23, 2017 11:30 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Immunoscore®, Immunosign® and...
HalioDx: New data on Halioseek(TM) PD-L1/CD8 presented at AACR 2017
March 31, 2017 13:09 ET
|
HalioDx
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
New data on Halioseek(TM) PD-L1/CD8...